Neuraxis, Inc. is an innovative medical technology company based in Versailles, Indiana, specializing in the development and commercialization of neuromodulation therapy devices aimed at addressing a range of neurological conditions. By leveraging cutting-edge technology and research, Neuraxis is positioned to enhance patient outcomes and improve quality of life through its advanced therapeutic solutions. The company's commitment to addressing unmet medical needs underscores its potential for growth and impact in the evolving neuromodulation sector.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

11611 NORTH MERIDIAN ST, CARMEL, IN, UNITED STATES, 46032

December

$31.4 Million

-$6.46 Million

0.0

-1.05

$0.00

0.0%

3.191